HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori.

AbstractOBJECTIVE:
To investigate the effect of plaunotol in combination with proton-pump inhibitors on Helicobacter pylori eradication in patients with gastric ulcer.
PATIENTS AND METHODS:
We studied 65 H. pylori-positive gastric ulcer patients. They were randomly assigned to five treatment groups: omeprazole (group I, n = 8), lansoprazole (group II, n = 13), lansoprazole+plaunotol (group III, n = 12), lansoprazole+clarithromycin (group IV, n = 16) and lansoprazole+plaunotol+clarithromycin (group V, n = 16). Ulcer status was diagnosed by endoscopy and H. pylori status by culture, histology, a urease test and a urea breath test at baseline, and after 8 and 12 weeks. The clearance and eradication rates were compared in each group.
RESULTS:
The healing rates in groups I-V were 100, 92, 100, 100 and 100%, respectively; clearance rates were 0, 23, 42, 50 and 75%, respectively; and eradication rates were 0, 0, 8, 38 and 69%, respectively.
CONCLUSION:
Combination therapy with plaunotol is efficacious for the eradication of H. pylori in gastric ulcer patients.
AuthorsY Fukuda, I Yamamoto, M Okui, Y Tonokatsu, K Tamura, T Shimoyama
JournalEuropean journal of gastroenterology & hepatology (Eur J Gastroenterol Hepatol) Vol. 7 Suppl 1 Pg. S45-7 (Aug 1995) ISSN: 0954-691X [Print] England
PMID8574735 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Diterpenes
  • Fatty Alcohols
  • Clarithromycin
  • plaunotol
Topics
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Anti-Ulcer Agents (administration & dosage, therapeutic use)
  • Biopsy
  • Clarithromycin (administration & dosage, therapeutic use)
  • Colony Count, Microbial
  • Diterpenes
  • Drug Therapy, Combination
  • Fatty Alcohols (administration & dosage, therapeutic use)
  • Gastric Mucosa (drug effects, microbiology)
  • Gastroscopy
  • Helicobacter Infections (complications, drug therapy, microbiology)
  • Helicobacter pylori (drug effects, isolation & purification)
  • Humans
  • Stomach Ulcer (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: